Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,664 across all filing types
Latest filing 2023-03-19 Investor Presentation
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
NWR Virtual Healthcare Conference 2 pages 176.6KB
Investor Presentation Classification · 95% confidence The document is an ASX announcement dated 20 March 2023, stating that Anteris Technologies Ltd will present at the NWR Virtual Healthcare Conference on 21 March 2023. It invites shareholders and investors to attend the presentation and provides links for registration and replay. The content is focused on announcing an upcoming investor presentation event rather than providing financial data or detailed report content. The document length is 2773 characters, which is relatively short and consistent with an announcement rather than a full report. There is no financial data, no detailed analysis, or regulatory filing content. Therefore, this document fits best as an Investor Presentation announcement (IP).
2023-03-19 English
Application for quotation of securities - AVR 9 pages 33.0KB
Share Issue/Capital Change Classification · 100% confidence The document is an application for quotation of securities on the ASX, detailing the issuance and conversion of options into ordinary fully paid shares. It includes specifics about the number of securities, issue dates, and the nature of the securities being quoted. There is no financial performance data, earnings information, or management discussion. The document is a formal announcement related to capital changes, specifically the issuance and quotation of new shares resulting from option exercises. This fits the category of Share Issue/Capital Change (SHA). The document length and content confirm it is not a brief announcement or a report publication notice but a substantive filing about capital changes.
2023-03-19 English
Preliminary Final Report 72 pages 1.2MB
Annual Report Classification · 100% confidence The document is an ASX announcement dated 28 February 2023, titled "APPENDIX 4E AND PRELIMINARY FINAL REPORT" for the year ended 31 December 2022. It contains detailed financial data including revenues, net loss, cash flow, and segment information. It also includes a Directors' Report, Auditor's Report, and full financial statements such as Consolidated Statement of Profit or Loss, Statement of Financial Position, and Notes to the Financial Statements. The document is comprehensive and covers the full fiscal year, indicating it is a full annual financial report. Appendix 4E is a regulatory filing in Australia that accompanies the preliminary final report, which is essentially the annual report. The presence of the Directors' Report and Auditor's Report confirms this is the full Annual Report. The document is about 15,000 characters, which is consistent with a full report rather than a short announcement or notice. Therefore, the correct classification is Annual Report (10-K). FY 2022
2023-02-27 English
Notification of cessation of securities - AVR 5 pages 25.7KB
Regulatory Filings Classification · 95% confidence The document is titled 'Notification of cessation of +securities' and details the lapse of certain options (securities) for Anteris Technologies Ltd. It provides specific information about the securities that have ceased, the reasons for cessation, and the updated issued capital following these changes. The document is an announcement about changes in the company's issued securities, specifically the cessation of certain options. It does not contain financial statements, management discussion, or detailed financial results. It is not a report but an official notification to the ASX about changes in securities. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-02-26 English
Settlement of $35M Capital Raising Transaction 2 pages 206.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 15 February 2023 regarding the settlement of a $35 million capital raising transaction by Anteris Technologies Ltd. It details the issuance of new shares, the investors involved, the use of proceeds, and upcoming clinical milestones. There is no financial report, earnings data, or detailed financial statements included. The content focuses on the capital raising event and related financing details. Therefore, this document fits the category of Capital/Financing Update (CAP). The document length is about 4955 characters, which is sufficient to be a full announcement rather than a brief notice or report publication announcement.
2023-02-14 English
Application for quotation of securities - AVR 8 pages 30.2KB
Capital/Financing Update Classification · 95% confidence The document is an application for quotation of securities on the ASX, detailing the number and type of securities to be quoted, issue dates, and related information. It references previous announcements (Appendix 3B) related to securities issuance and capital raising. The content focuses on the issuance and quotation of new shares and options, including details about the capital structure post-quotation. There are no financial statements, earnings data, management discussion, or regulatory certifications. The document is clearly about a capital market transaction involving new securities issuance and quotation. Therefore, it fits the category of Capital/Financing Update (CAP). The document length (7002 characters) and detailed issuance data support this classification with high confidence.
2023-02-14 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.